Glucose Dependent Insulinotropic Receptor Pipeline Report: Encapsulates all the Dormant and Discontinued Pipeline Projects
'Glucose Dependent Insulinotropic Receptor Pipeline Review, H1 2018' outlays comprehensive information on the Glucose Dependent Insulinotropic Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of acti
(EMAILWIRE.COM, April 03, 2018 ) Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) G protein-coupled receptor 119 also known as GPR119 is a G protein-coupled receptor that is encoded by the GPR119 gene. GPR119 is expressed at high concentrations in the pancreas and gastrointestinal tract. GPR119 regulates incretin and insulin hormone secretion. Activation of GPR119 receptor causes a reduction in food intake and weight gain. This target is a potential drug target in treatments for obesity and diabetes.
Report Source: https://www.themarketreports.com/report/glucose-dependent-insulinotropic-receptor-g-protein-coupled-receptor-119-or-gpr119-pipeline-review-h1-2018
Reasons to buy
Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand the targeted therapy areas and indications for Glucose Dependent Insulinotropic Receptor
Identify the use of drugs for target identification and drug repurposing
Identify potential new clients or partners in the target demographic
Develop strategic initiatives by understanding the focus areas of leading companies
Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
Devise corrective measures for pipeline projects by understanding Glucose Dependent Insulinotropic Receptor development landscape
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Purchase this report at: https://www.themarketreports.com/report/buy-now/987789
Companies Mentioned
Amgen Inc
Arena Pharmaceuticals Inc
CymaBay Therapeutics Inc
Dong-A Socio Holdings Co Ltd
GlaxoSmithKline Plc
Hyundai Pharmaceutical Co Ltd
Kowa Co Ltd
Merck & Co Inc
Novartis AG
Taisho Pharmaceutical Holdings Co Ltd
Takeda Pharmaceutical Co Ltd
Yuhan Corp
Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/987789
Report Source: https://www.themarketreports.com/report/glucose-dependent-insulinotropic-receptor-g-protein-coupled-receptor-119-or-gpr119-pipeline-review-h1-2018
Reasons to buy
Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand the targeted therapy areas and indications for Glucose Dependent Insulinotropic Receptor
Identify the use of drugs for target identification and drug repurposing
Identify potential new clients or partners in the target demographic
Develop strategic initiatives by understanding the focus areas of leading companies
Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
Devise corrective measures for pipeline projects by understanding Glucose Dependent Insulinotropic Receptor development landscape
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Purchase this report at: https://www.themarketreports.com/report/buy-now/987789
Companies Mentioned
Amgen Inc
Arena Pharmaceuticals Inc
CymaBay Therapeutics Inc
Dong-A Socio Holdings Co Ltd
GlaxoSmithKline Plc
Hyundai Pharmaceutical Co Ltd
Kowa Co Ltd
Merck & Co Inc
Novartis AG
Taisho Pharmaceutical Holdings Co Ltd
Takeda Pharmaceutical Co Ltd
Yuhan Corp
Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/987789
Contact Information:
The Market Reports
Shirish Gupta
Tel: +1-631-407-1315
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
The Market Reports
Shirish Gupta
Tel: +1-631-407-1315
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results